
The Risks of Using AI in Regulatory Dossier Translation: Hallucinations and Critical Errors
AI is rapidly reshaping how life sciences organisations work — and translation is no exception. Faced with ever-growing submission volumes, compressed timelines and global programmes that rarely run sequentially, many Regulatory Affairs teams are understandably asking the same question: can AI help us translate faster, and still submit with confidence? The short









